Article thumbnail

Multiparameter RNA and Codon Optimization: A Standardized Tool to Assess and Enhance Autologous Mammalian Gene Expression

By Stephan Fath, Asli Petra Bauer, Michael Liss, Anne Spriestersbach, Barbara Maertens, Peter Hahn, Christine Ludwig, Frank Schäfer, Marcus Graf and Ralf Wagner

Abstract

Autologous expression of recombinant human proteins in human cells for biomedical research and product development is often hampered by low expression yields limiting subsequent structural and functional analyses. Following RNA and codon optimization, 50 candidate genes representing five classes of human proteins – transcription factors, ribosomal and polymerase subunits, protein kinases, membrane proteins and immunomodulators – all showed reliable, and 86% even elevated expression. Analysis of three representative examples showed no detrimental effect on protein solubility while unaltered functionality was demonstrated for JNK1, JNK3 and CDC2 using optimized constructs. Molecular analysis of a sequence-optimized transgene revealed positive effects at transcriptional, translational, and mRNA stability levels. Since improved expression was consistent in HEK293T, CHO and insect cells, it was not restricted to distinct mammalian cell systems. Additionally, optimized genes represent powerful tools in functional genomics, as demonstrated by the successful rescue of an siRNA-mediated knockdown using a sequence-optimized counterpart. This is the first large-scale study addressing the influence of multiparameter optimization on autologous human protein expression

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3048298
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1996). A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells.
  2. (2001). A new mathematical model for relative quantification in realtime RT-PCR.
  3. (2010). A role for codon order in translation dynamics.
  4. (1991). An element in the bovine papillomavirus late 39 untranslated region reduces polyadenylated cytoplasmic RNA levels.
  5. (2008). Bhujanga Rao AK
  6. (2009). Coding-sequence determinants of gene expression in Escherichia coli.
  7. (2004). Codon bias and heterologous protein expression.
  8. (2008). Codon optimization can improve expression of human genes in Escherichia coli: A multi-gene study.
  9. (2004). Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression.
  10. (1999). Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch.
  11. (1990). Codon preferences in free-living microorganisms.
  12. (2004). Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA. Methods Mol.
  13. (2005). Codon-optimized reading frames facilitate highlevel expression of the HIV-1 minor proteins.
  14. (2000). Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression.
  15. (1995). Consecutive lowusage leucine codons block translation only when near the 59 end of a message in Escherichia coli.
  16. (2003). CpG content affects gene silencing in mice: evidence from novel transgenes.
  17. (2009). Design parameters to control synthetic gene expression in Escherichia coli.
  18. (1992). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.
  19. (1992). Efficiency of the 59-terminal sequence (omega) of tobacco mosaic virus RNA for the initiation of eukaryotic gene translation in Escherichia coli.
  20. (1995). Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1.
  21. (1991). Efficient expression of the Paramecium calmodulin gene in Escherichia coli after four TAA-to-CAA changes through a series of polymerase chain reactions.
  22. (2008). Expression of human nPTB is limited by extreme suboptimal codon content.
  23. (2002). Expression systems for production of recombinant allergens.
  24. (1978). Globin mRNA sequences: analysis of base pairing and evolutionary implications.
  25. (2006). High guanine and cytosine content increases mRNA levels in mammalian cells.
  26. (1991). Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation.
  27. (2005). Improved heterologous gene expression in Escherichia coli by optimization of the ATcontent of codons immediately downstream of the initiation codon.
  28. (1997). Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.
  29. (1998). Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage.
  30. (1984). Influence of messenger RNA secondary structure on translation efficiency.
  31. (2003). Mammalian mutation pressure, synonymous codon choice, and mRNA degradation.
  32. (2010). Minimal doses of a sequence- optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design. Gene Therapy.
  33. (1995). mRNA decay mediated by two distinct AUrich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation.
  34. (1998). mRNA instability elements in the human papillomavirus type 16 L2 coding region.
  35. (2000). Nuclear run-on assay using biotin labeling, magnetic bead capture and analysis by fluorescence-based RT-PCR.
  36. (2010). On Relevance of Codon Usage to Expression of Synthetic and Natural Genes in Escherichia coli.
  37. (2000). Optimizing heterologous expression in dictyostelium: importance of 59 codon adaptation.
  38. (1999). Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.
  39. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells.
  40. (2008). Production systems for recombinant antibodies.
  41. (2002). Real-time RT-PCR analysis of mRNA decay: half-life of Beta-actin mRNA
  42. (1996). Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells.
  43. (2009). Selecting an appropriate method for expressing a recombinant protein.
  44. (1996). Strategies for achieving high-level expression of genes in Escherichia coli.
  45. (1987). The codon Adaptation Index–a measure of directional synonymous codon usage bias, and its potential applications.
  46. (2010). The GeneOptimizer Algorithm: Using a sliding window approach to cope with the vast sequence space in multiparameter DNA sequence optimization.
  47. (2010). The impact of intragenic CpG content on gene expression.
  48. (2005). The role of the AU-rich elements of mRNAs in controlling translation.
  49. (1995). The stability of Escherichia coli lacZ mRNA depends upon the simultaneity of its synthesis and translation.
  50. (2004). Tissue-specific codon usage and the expression of human genes.
  51. (2006). Tissue-specific differences in human transfer RNA expression.